Cheryl R. Blanchard - Apr 26, 2023 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
President, CEO, Director, Director
Signature
/s/ Cheryl R. Blanchard
Stock symbol
ANIK
Transactions as of
Apr 26, 2023
Transactions value $
-$287,106
Form type
4
Date filed
4/28/2023, 04:30 PM
Previous filing
Mar 14, 2023
Next filing
Jun 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Options Exercise $0 +24.6K +24.43% $0.00 125K Apr 26, 2023 Direct F1
transaction ANIK Common Stock Tax liability -$287K -10.9K -8.71% $26.34 114K Apr 26, 2023 Direct F2, F3
holding ANIK Common Stock 11.7K Apr 26, 2023 Revocable Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIK Restricted Stock Unit Options Exercise $0 -24.6K -100% $0.00* 0 Apr 26, 2023 Common Stock 24.6K $0.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on April 26, 2020.
F2 Reflects an aggregate of 10,900 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on April 26, 2023.
F3 Reflects the closing price of ANIK common stock on April 26, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
F4 Consists of shares transferred by Dr. Blanchard to The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which Dr. Blanchard is a beneficiary and the sole trustee.
F5 Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning April 26, 2021.